Institut Cancerologie De L'ouest
Clinical trials sponsored by Institut Cancerologie De L'ouest, explained in plain language.
-
New bladder cancer treatment aims to destroy tumors without removing the bladder
Disease control Not yet recruitingThis early-phase trial is testing a new drug called ATO-101 for people with a type of bladder cancer (non-muscle-invasive) that has come back after standard treatments like BCG therapy. The drug delivers a short-range radioactive particle directly to cancer cells in the bladder, …
Phase: PHASE1 • Sponsor: Institut Cancerologie de l'Ouest • Aim: Disease control
Last updated May 16, 2026 23:37 UTC
-
New radiation approach aims to delay pain in Tough-to-Treat prostate cancer
Disease control Not yet recruitingThis early-phase study tests a precise radiation technique (stereotactic radiotherapy) in 18 men with advanced prostate cancer that has spread to bones or lymph nodes and is no longer responding to standard treatments. The goal is to find the largest total volume of tumors that c…
Phase: NA • Sponsor: Institut Cancerologie de l'Ouest • Aim: Disease control
Last updated May 12, 2026 13:42 UTC
-
New device could ease joint pain for breast cancer survivors
Symptom relief Not yet recruitingThis study tests a non-invasive device that stimulates a nerve in the ear to reduce joint pain and stiffness caused by aromatase inhibitors, a common breast cancer treatment. About 60 women with hormone-positive breast cancer who experience joint pain will receive either the acti…
Phase: NA • Sponsor: Institut Cancerologie de l'Ouest • Aim: Symptom relief
Last updated May 16, 2026 23:37 UTC